Global Hydroxycarbamide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024


    Table of Contents

      1 Market Overview

      • 1.1 Hydroxycarbamide Introduction
      • 1.2 Market Analysis by Type
        • 1.2.1 Capsule
        • 1.2.2 Tablet
      • 1.3 Market Analysis by Applications
        • 1.3.1 Sickle Cell Disease
        • 1.3.2 Cancer
        • 1.3.3 Other
      • 1.4 Market Analysis by Regions
        • 1.4.1 North America (United States, Canada and Mexico)
          • 1.4.1.1 United States Market States and Outlook (2014-2024)
          • 1.4.1.2 Canada Market States and Outlook (2014-2024)
          • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
        • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
          • 1.4.2.1 Germany Market States and Outlook (2014-2024)
          • 1.4.2.2 France Market States and Outlook (2014-2024)
          • 1.4.2.3 UK Market States and Outlook (2014-2024)
          • 1.4.2.4 Russia Market States and Outlook (2014-2024)
          • 1.4.2.5 Italy Market States and Outlook (2014-2024)
        • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
          • 1.4.3.1 China Market States and Outlook (2014-2024)
          • 1.4.3.2 Japan Market States and Outlook (2014-2024)
          • 1.4.3.3 Korea Market States and Outlook (2014-2024)
          • 1.4.3.4 India Market States and Outlook (2014-2024)
          • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        • 1.4.4 South America, Middle East and Africa
          • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
          • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
          • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
          • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
          • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
      • 1.5 Market Dynamics
        • 1.5.1 Market Opportunities
        • 1.5.2 Market Risk
        • 1.5.3 Market Driving Force

      2 Manufacturers Profiles

      • 2.1 Bristol Myers Squibb
        • 2.1.1 Business Overview
        • 2.1.2 Hydroxycarbamide Type and Applications
          • 2.1.2.1 Product A
          • 2.1.2.2 Product B
        • 2.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.2 Taj Pharma
        • 2.2.1 Business Overview
        • 2.2.2 Hydroxycarbamide Type and Applications
          • 2.2.2.1 Product A
          • 2.2.2.2 Product B
        • 2.2.3 Taj Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.3 Beijing Jialin Pharma
        • 2.3.1 Business Overview
        • 2.3.2 Hydroxycarbamide Type and Applications
          • 2.3.2.1 Product A
          • 2.3.2.2 Product B
        • 2.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.4 Qilu Pharmaceutical
        • 2.4.1 Business Overview
        • 2.4.2 Hydroxycarbamide Type and Applications
          • 2.4.2.1 Product A
          • 2.4.2.2 Product B
        • 2.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.5 Teva Pharma
        • 2.5.1 Business Overview
        • 2.5.2 Hydroxycarbamide Type and Applications
          • 2.5.2.1 Product A
          • 2.5.2.2 Product B
        • 2.5.3 Teva Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.6 Cipla
        • 2.6.1 Business Overview
        • 2.6.2 Hydroxycarbamide Type and Applications
          • 2.6.2.1 Product A
          • 2.6.2.2 Product B
        • 2.6.3 Cipla Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.7 Zydus Cadila
        • 2.7.1 Business Overview
        • 2.7.2 Hydroxycarbamide Type and Applications
          • 2.7.2.1 Product A
          • 2.7.2.2 Product B
        • 2.7.3 Zydus Cadila Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.8 United Biotech
        • 2.8.1 Business Overview
        • 2.8.2 Hydroxycarbamide Type and Applications
          • 2.8.2.1 Product A
          • 2.8.2.2 Product B
        • 2.8.3 United Biotech Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.9 Par Pharma
        • 2.9.1 Business Overview
        • 2.9.2 Hydroxycarbamide Type and Applications
          • 2.9.2.1 Product A
          • 2.9.2.2 Product B
        • 2.9.3 Par Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.10 Khandelwal Laboratories
        • 2.10.1 Business Overview
        • 2.10.2 Hydroxycarbamide Type and Applications
          • 2.10.2.1 Product A
          • 2.10.2.2 Product B
        • 2.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.11 Alkem (Cytomed)
        • 2.11.1 Business Overview
        • 2.11.2 Hydroxycarbamide Type and Applications
          • 2.11.2.1 Product A
          • 2.11.2.2 Product B
        • 2.11.3 Alkem (Cytomed) Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.12 Samarth Pharma
        • 2.12.1 Business Overview
        • 2.12.2 Hydroxycarbamide Type and Applications
          • 2.12.2.1 Product A
          • 2.12.2.2 Product B
        • 2.12.3 Samarth Pharma Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.13 VHB Life Sciences
        • 2.13.1 Business Overview
        • 2.13.2 Hydroxycarbamide Type and Applications
          • 2.13.2.1 Product A
          • 2.13.2.2 Product B
        • 2.13.3 VHB Life Sciences Hydroxycarbamide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

      3 Global Hydroxycarbamide Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

      • 3.1 Global Hydroxycarbamide Sales and Market Share by Manufacturer (2017-2018)
      • 3.2 Global Hydroxycarbamide Revenue and Market Share by Manufacturer (2017-2018)
      • 3.3 Market Concentration Rate
        • 3.3.1 Top 3 Hydroxycarbamide Manufacturer Market Share in 2018
        • 3.3.2 Top 6 Hydroxycarbamide Manufacturer Market Share in 2018
      • 3.4 Market Competition Trend

      4 Global Hydroxycarbamide Market Analysis by Regions

      • 4.1 Global Hydroxycarbamide Sales, Revenue and Market Share by Regions
        • 4.1.1 Global Hydroxycarbamide Sales and Market Share by Regions (2014-2019)
        • 4.1.2 Global Hydroxycarbamide Revenue and Market Share by Regions (2014-2019)
      • 4.2 North America Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 4.3 Europe Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 4.4 Asia-Pacific Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 4.5 South America Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 4.6 Middle East and Africa Hydroxycarbamide Sales and Growth Rate (2014-2019)

      5 North America Hydroxycarbamide by Country

      • 5.1 North America Hydroxycarbamide Sales, Revenue and Market Share by Country
        • 5.1.1 North America Hydroxycarbamide Sales and Market Share by Country (2014-2019)
        • 5.1.2 North America Hydroxycarbamide Revenue and Market Share by Country (2014-2019)
      • 5.2 United States Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 5.3 Canada Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 5.4 Mexico Hydroxycarbamide Sales and Growth Rate (2014-2019)

      6 Europe Hydroxycarbamide by Country

      • 6.1 Europe Hydroxycarbamide Sales, Revenue and Market Share by Country
        • 6.1.1 Europe Hydroxycarbamide Sales and Market Share by Country (2014-2019)
        • 6.1.2 Europe Hydroxycarbamide Revenue and Market Share by Country (2014-2019)
      • 6.2 Germany Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 6.3 UK Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 6.4 France Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 6.5 Russia Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 6.6 Italy Hydroxycarbamide Sales and Growth Rate (2014-2019)

      7 Asia-Pacific Hydroxycarbamide by Country

      • 7.1 Asia-Pacific Hydroxycarbamide Sales, Revenue and Market Share by Country
        • 7.1.1 Asia-Pacific Hydroxycarbamide Sales and Market Share by Country (2014-2019)
        • 7.1.2 Asia-Pacific Hydroxycarbamide Revenue and Market Share by Country (2014-2019)
      • 7.2 China Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 7.3 Japan Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 7.4 Korea Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 7.5 India Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 7.6 Southeast Asia Hydroxycarbamide Sales and Growth Rate (2014-2019)

      8 South America Hydroxycarbamide by Country

      • 8.1 South America Hydroxycarbamide Sales, Revenue and Market Share by Country
        • 8.1.1 South America Hydroxycarbamide Sales and Market Share by Country (2014-2019)
        • 8.1.2 South America Hydroxycarbamide Revenue and Market Share by Country (2014-2019)
      • 8.2 Brazil Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 8.3 Argentina Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 8.4 Colombia Hydroxycarbamide Sales and Growth Rate (2014-2019)

      9 Middle East and Africa Hydroxycarbamide by Countries

      • 9.1 Middle East and Africa Hydroxycarbamide Sales, Revenue and Market Share by Country
        • 9.1.1 Middle East and Africa Hydroxycarbamide Sales and Market Share by Country (2014-2019)
        • 9.1.2 Middle East and Africa Hydroxycarbamide Revenue and Market Share by Country (2014-2019)
      • 9.2 Saudi Arabia Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 9.3 Turkey Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 9.4 Egypt Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 9.5 Nigeria Hydroxycarbamide Sales and Growth Rate (2014-2019)
      • 9.6 South Africa Hydroxycarbamide Sales and Growth Rate (2014-2019)

      10 Global Hydroxycarbamide Market Segment by Type

      • 10.1 Global Hydroxycarbamide Sales, Revenue and Market Share by Type (2014-2019)
        • 10.1.1 Global Hydroxycarbamide Sales and Market Share by Type (2014-2019)
        • 10.1.2 Global Hydroxycarbamide Revenue and Market Share by Type (2014-2019)
      • 10.2 Capsule Sales Growth and Price
        • 10.2.1 Global Capsule Sales Growth (2014-2019)
        • 10.2.2 Global Capsule Price (2014-2019)
      • 10.3 Tablet Sales Growth and Price
        • 10.3.1 Global Tablet Sales Growth (2014-2019)
        • 10.3.2 Global Tablet Price (2014-2019)

      11 Global Hydroxycarbamide Market Segment by Application

      • 11.1 Global Hydroxycarbamide Sales Market Share by Application (2014-2019)
      • 11.2 Sickle Cell Disease Sales Growth (2014-2019)
      • 11.3 Cancer Sales Growth (2014-2019)
      • 11.4 Other Sales Growth (2014-2019)

      12 Hydroxycarbamide Market Forecast (2019-2024)

      • 12.1 Global Hydroxycarbamide Sales, Revenue and Growth Rate (2019-2024)
      • 12.2 Hydroxycarbamide Market Forecast by Regions (2019-2024)
        • 12.2.1 North America Hydroxycarbamide Market Forecast (2019-2024)
        • 12.2.2 Europe Hydroxycarbamide Market Forecast (2019-2024)
        • 12.2.3 Asia-Pacific Hydroxycarbamide Market Forecast (2019-2024)
        • 12.2.4 South America Hydroxycarbamide Market Forecast (2019-2024)
        • 12.2.5 Middle East and Africa Hydroxycarbamide Market Forecast (2019-2024)
      • 12.3 Hydroxycarbamide Market Forecast by Type (2019-2024)
        • 12.3.1 Global Hydroxycarbamide Sales Forecast by Type (2019-2024)
        • 12.3.2 Global Hydroxycarbamide Market Share Forecast by Type (2019-2024)
      • 12.4 Hydroxycarbamide Market Forecast by Application (2019-2024)
        • 12.4.1 Global Hydroxycarbamide Sales Forecast by Application (2019-2024)
        • 12.4.2 Global Hydroxycarbamide Market Share Forecast by Application (2019-2024)

      13 Sales Channel, Distributors, Traders and Dealers

      • 13.1 Sales Channel
        • 13.1.1 Direct Marketing
        • 13.1.2 Indirect Marketing
        • 13.1.3 Marketing Channel Future Trend
      • 13.2 Distributors, Traders and Dealers

      14 Research Findings and Conclusion

        15 Appendix

        • 15.1 Methodology

        Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
        Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.

        Scope of the Report:
        The classification of Hydroxycarbamide includes capsule and tablet, and the proportion of capsule in 2016 is about 63%, and the proportion is in decreasing trend from 2012 to 2016.
        Hydroxycarbamide is widely used for sickle cell disease, cancer and other disease. The most proportion of Hydroxycarbamide is used for sickle cell disease, and the proportion in 2016 is 45%.
        Asia Pacific is the largest supplier of Hydroxycarbamide, with a production market share nearly 59% in 2016.
        Middle East and Africa is the largest consumption place, with a consumption market share nearly 36% in 2016. Following Middle East and Africa, Asia Pacific is the second largest consumption place with the consumption market share of 20%.
        Market competition is not intense. Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech, Par Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
        The worldwide market for Hydroxycarbamide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
        This report focuses on the Hydroxycarbamide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

        Market Segment by Manufacturers, this report covers
        Bristol Myers Squibb
        Taj Pharma
        Beijing Jialin Pharma
        Qilu Pharmaceutical
        Teva Pharma
        Cipla
        Zydus Cadila
        United Biotech
        Par Pharma
        Khandelwal Laboratories
        Alkem (Cytomed)
        Samarth Pharma
        VHB Life Sciences

        Market Segment by Regions, regional analysis covers
        North America (United States, Canada and Mexico)
        Europe (Germany, France, UK, Russia and Italy)
        Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        South America (Brazil, Argentina, Colombia etc.)
        Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

        Market Segment by Type, covers
        Capsule
        Tablet

        Market Segment by Applications, can be divided into
        Sickle Cell Disease
        Cancer
        Other

        The content of the study subjects, includes a total of 15 chapters:
        Chapter 1, to describe Hydroxycarbamide product scope, market overview, market opportunities, market driving force and market risks.
        Chapter 2, to profile the top manufacturers of Hydroxycarbamide, with price, sales, revenue and global market share of Hydroxycarbamide in 2017 and 2018.
        Chapter 3, the Hydroxycarbamide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
        Chapter 4, the Hydroxycarbamide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
        Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
        Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
        Chapter 12, Hydroxycarbamide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
        Chapter 13, 14 and 15, to describe Hydroxycarbamide sales channel, distributors, customers, research findings and conclusion, appendix and data source.



        Summary:
        Hydroxycarbamide Market Research Reports - Hydroxycarbamide Market Analysis, Trends & Statistics. Industry analysis and Market Report on Hydroxycarbamide is a syndicated market report, published as Hydroxycarbamide. It is complete Research Study and Industry Analysis of Hydroxycarbamide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.



        REPORT YOU MIGHT BE INTERESTED